Yinxiang Wei

763 total citations
22 papers, 544 citations indexed

About

Yinxiang Wei is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Yinxiang Wei has authored 22 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 11 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Yinxiang Wei's work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (4 papers). Yinxiang Wei is often cited by papers focused on Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (4 papers). Yinxiang Wei collaborates with scholars based in China, United States and South Korea. Yinxiang Wei's co-authors include Renxi Wang, Xiaoqian Wang, Guojiang Chen, Gencheng Han, Chunmei Hou, Yuanfang Ma, Bing Shen, Yu Zhang, Ning Ma and Xiaoling Liu and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and European Journal of Immunology.

In The Last Decade

Yinxiang Wei

20 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yinxiang Wei China 11 269 234 107 74 52 22 544
Sybille Schmid Germany 6 223 0.8× 224 1.0× 85 0.8× 108 1.5× 38 0.7× 6 512
Elisabeth Glitzner Austria 10 235 0.9× 191 0.8× 122 1.1× 93 1.3× 23 0.4× 12 681
Yucheng Zhong China 17 195 0.7× 402 1.7× 98 0.9× 55 0.7× 49 0.9× 24 632
Hongjun Zhao China 14 314 1.2× 152 0.6× 81 0.8× 151 2.0× 100 1.9× 47 615
Hongyan Sun China 15 289 1.1× 88 0.4× 124 1.2× 180 2.4× 68 1.3× 60 627
Hye‐Jin Son South Korea 8 247 0.9× 266 1.1× 116 1.1× 53 0.7× 43 0.8× 10 601
Inés Roger Spain 9 156 0.6× 111 0.5× 85 0.8× 29 0.4× 47 0.9× 33 582
Anissa A. Widjaja Singapore 16 229 0.9× 208 0.9× 176 1.6× 42 0.6× 72 1.4× 29 752
Junaid Ansari United States 13 336 1.2× 142 0.6× 91 0.9× 112 1.5× 45 0.9× 27 697
Tomoko Ota Japan 12 163 0.6× 79 0.3× 193 1.8× 75 1.0× 60 1.2× 22 507

Countries citing papers authored by Yinxiang Wei

Since Specialization
Citations

This map shows the geographic impact of Yinxiang Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinxiang Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinxiang Wei more than expected).

Fields of papers citing papers by Yinxiang Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinxiang Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinxiang Wei. The network helps show where Yinxiang Wei may publish in the future.

Co-authorship network of co-authors of Yinxiang Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Yinxiang Wei. A scholar is included among the top collaborators of Yinxiang Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinxiang Wei. Yinxiang Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Dan, Zihui Wang, Yanyan Chen, et al.. (2025). GDF11 alleviates cardiac ischemia/reperfusion injury by suppressing the mtDNA damage-inflammatory response axis. European Journal of Pharmacology. 993. 177392–177392.
2.
Zhang, Lijie, Xinyuan Zhang, Ziting Li, et al.. (2025). Attenuation of cardiac ischemia/reperfusion injury via the decoy receptor DcR2 by targeting the PLAD domain of the death receptor DR5. International Journal of Biological Macromolecules. 308(Pt 3). 142529–142529. 1 indexed citations
3.
Wang, Zhiwei, Fan Wu, Yinxiang Wei, et al.. (2025). Coordination of Neutrophil and Apoptosis-Inducing Ligand in Inflammatory Diseases. Journal of Inflammation Research. Volume 18. 3607–3621.
4.
Wei, Zeliang, Shanshan Jia, Yao Wang, et al.. (2024). Development of novel monoclonal antibodies for blocking NF-κB activation induced by CD2v protein in African swine fever virus. Frontiers in Immunology. 15. 1352404–1352404. 1 indexed citations
5.
Zhao, Dan, Guiling Wang, Lijie Zhang, et al.. (2024). Blocking the TRAIL-DR5 Pathway Reduces Cardiac Ischemia–Reperfusion Injury by Decreasing Neutrophil Infiltration and Neutrophil Extracellular Traps Formation. Cardiovascular Drugs and Therapy. 39(5). 983–999. 3 indexed citations
6.
Zhou, Jie, Meichen Liu, Lin Du, et al.. (2024). Ubiquitination and degradation of MHC-II by Tim-3 inhibits antiviral immunity. Cellular Immunology. 407. 104889–104889. 1 indexed citations
7.
Li, Kaitong, Qingbin Meng, Meng Zhao, et al.. (2024). Unveiling novel insights into human IL-6 − IL-6R interaction sites through 3D computer-guided docking and systematic site mutagenesis. Scientific Reports. 14(1). 18293–18293. 1 indexed citations
8.
Li, Peiyao, et al.. (2023). Tim-3 protects against cisplatin nephrotoxicity by inhibiting NF-κB-mediated inflammation. Cell Death Discovery. 9(1). 218–218. 10 indexed citations
9.
Wei, Yinxiang, Weina Zhu, Xi Chen, et al.. (2022). TRAIL inhibition by soluble death receptor 5 protects against acute myocardial infarction in rats. Heart and Vessels. 38(3). 448–458. 3 indexed citations
10.
Ma, Yuting, Shaowei Li, Shuang Yang, et al.. (2020). 1,25(OH)2D3 alleviates DSS-induced ulcerative colitis via inhibiting NLRP3 inflammasome activation. Journal of Leukocyte Biology. 108(1). 283–295. 38 indexed citations
11.
Liu, Xiaoling, Yu Zhang, Yinxiang Wei, et al.. (2019). The E3 ubiquitin ligase Itch is required for B-cell development. Scientific Reports. 9(1). 421–421. 15 indexed citations
12.
Wei, Yinxiang, Fanghui Zhang, Yu Zhang, et al.. (2018). Post-transcriptional regulator Rbm47 elevates IL-10 production and promotes the immunosuppression of B cells. Cellular and Molecular Immunology. 16(6). 580–589. 27 indexed citations
13.
Wang, Xiaoqian, Yinxiang Wei, Xiao He, et al.. (2016). Pre-existing CD19-independent GL7 − Breg cells are expanded during inflammation and in mice with lupus-like disease. Molecular Immunology. 71. 54–63. 22 indexed citations
14.
Wang, Xiaoqian, Yinxiang Wei, Xiao He, et al.. (2016). A novel IL‐23p19/Ebi3 (IL‐39) cytokine mediates inflammation in Lupus‐like mice. European Journal of Immunology. 46(6). 1343–1350. 134 indexed citations
15.
Wang, Xiaoqian, Xiao He, Yinxiang Wei, et al.. (2015). Experimental immunology<br>Blockade of B-cell activating factor with TACI-IgG effectively reduced Th1 and Th17 cells but not memory T cells in experimental allergic encephalomyelitis mice. Central European Journal of Immunology. 40(2). 142–148. 7 indexed citations
16.
Ma, Ning, Xiaoling Liu, Xing Chen, et al.. (2015). Ligation of metabotropic glutamate receptor 3 (Grm3) ameliorates lupus-like disease by reducing B cells. Clinical Immunology. 160(2). 142–154. 17 indexed citations
17.
Wang, Xiaoqian, Yinxiang Wei, Xiaoling Liu, et al.. (2015). IL-15-secreting γδT cells induce memory T cells in experimental allergic encephalomyelitis (EAE) mice. Molecular Immunology. 66(2). 402–408. 10 indexed citations
18.
Yang, Fei, Yinxiang Wei, Lei Yu, et al.. (2014). Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling. Cellular and Molecular Immunology. 12(1). 66–76. 20 indexed citations
19.
Yu, Lei, Fei Yang, Lingling Jiang, et al.. (2013). Exosomes with membrane‐associated TGF‐β1 from gene‐modified dendritic cells inhibit murine EAE independently of MHC restriction. European Journal of Immunology. 43(9). 2461–2472. 73 indexed citations
20.
Wei, Yinxiang, Yuanfang Ma, Qing Zhao, et al.. (2012). New Use for an Old Drug: Inhibiting ABCG2 with Sorafenib. Molecular Cancer Therapeutics. 11(8). 1693–1702. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sybille Schmid Breakdown of academic impact, for papers by Elisabeth Glitzner Breakdown of academic impact, for papers by Yucheng Zhong Breakdown of academic impact, for papers by Hongjun Zhao Breakdown of academic impact, for papers by Hongyan Sun Breakdown of academic impact, for papers by Hye‐Jin Son Breakdown of academic impact, for papers by Inés Roger Breakdown of academic impact, for papers by Anissa A. Widjaja Breakdown of academic impact, for papers by Junaid Ansari Breakdown of academic impact, for papers by Tomoko Ota
Rankless by CCL
2026